Kezar Life Sciences Operating Expenses 2011-2026 | KZR

Annual Operating Expenses Kezar Life Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
59.1 M	90.6 M	118 M	71.2 M	54.7 M	43 M	37.3 M	24.7 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
118 M	24.7 M	62.4 M

Quarterly Operating Expenses Kezar Life Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
11.7 M	14.6 M	17.6 M	-	21.9 M	23.4 M	23.7 M	-	32.5 M	26.8 M	24.5 M	-	18.9 M	16.3 M	15.9 M	-	14.5 M	13 M	13 M	11.1 M	11.6 M	9.85 M	10.5 M	10 M	9.68 M	9.36 M	8.31 M	6.43 M	6.26 M	6.95 M	5.09 M	2.42 M	2.19 M	1.88 M	2.26 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
32.5 M	1.88 M	13 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Axcella Health AXLA	77 M	-	-16.42 %	$ 249 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
CASI Pharmaceuticals CASI	38.9 M	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Завод ДИОД DIOD	249 M	-	-	-	Russia
Фармсинтез LIFE	201 M	-	-	-	Russia
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Chimerix CMRX	93.4 M	-	-	$ 756 M	USA
Teligent, Inc. TLGT	548 K	-	-13.85 %	$ 16.1 M	USA
AbbVie ABBV	12.8 B	$ 208.7	-0.07 %	$ 369 B	USA
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	26.7 M	-	-3.03 %	$ 260 M	USA
Viela Bio, Inc. VIE	163 M	-	-	$ 2.91 B	USA
AbCellera Biologics ABCL	292 M	$ 3.52	-0.14 %	$ 1.05 B	Canada